Is a higher neutrophil-to-lymphocyte ratio a marker of innate-immune–leaning inflammation linked to insulin resistance?

The Neutrophil-to-Lymphocyte Ratio (NLR) is an increasingly utilized biomarker that reflects the interplay between the innate and adaptive immune systems. In clinical practice, an elevated NLR serves as a proxy for systemic inflammation, specifically characterized by an "innate-immune-leaning" profile.

Clinical and effectiveness evidence

Large-scale epidemiological data and meta-analyses consistently link higher NLR values to cardiometabolic dysfunction.

• Insulin Resistance: Research involving over 70,000 participants confirms that NLR is significantly higher in individuals with metabolic syndrome compared to healthy controls. Furthermore, elevated NLR values correlate positively with Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) scores, particularly in overweight and obese populations.
• Predictive Value: Higher NLR is associated with an increased incidence of metabolic syndrome and is a validated predictor of cardiovascular mortality. In clinical cohorts, the ratio often outperforms individual white blood cell counts in identifying patients at risk for metabolic disorders.

Mechanistic explanations

The relationship between NLR and insulin resistance is driven by specific cellular pathways that favor innate immune activation over adaptive responses.

• Innate Dominance: An elevated NLR indicates a shift toward neutrophil-driven activity. Neutrophils contribute to systemic inflammation by releasing reactive oxygen species (ROS), pro-inflammatory cytokines, and neutrophil extracellular traps (NETs).
• Adaptive Suppression: High-density neutrophils can overproduce hydrogen peroxide, which directly inhibits lymphocyte proliferation. This resulting lymphopenia further skews the immune balance toward an innate-dominant state.
• Metabolic Disruption: Systemic inflammation triggered by this innate dominance activates pathways such as the NLRP3 inflammasome. This activation leads to the release of IL-1β and IL-18, cytokines known to interfere with insulin receptor substrate-1 (IRS-1) phosphorylation. This molecular interference directly impairs cellular glucose uptake, manifesting as insulin resistance.

Bottom line

A higher neutrophil-to-lymphocyte ratio is a scientifically supported indicator of innate-immune-leaning systemic inflammation. It serves as a reliable biomarker for identifying insulin resistance and elevated cardiometabolic risk, reflecting a physiological state where chronic innate immune activation disrupts metabolic signaling.